121 related articles for article (PubMed ID: 34608936)
1. COVID-19-Related Submission Priorities From the Journal of the Pediatric Infectious Diseases Society.
Green M; Adler-Shohet FC; Blyth CC; Chiotos K; Gerber JS; Jhaveri R; Kociolek L; Martin-Blais R; Palazzi D; Shane AL; Schuster JE; Shulman ST; Storch GA; Weinberg GA; Zaoutis T
J Pediatric Infect Dis Soc; 2022 Jan; 11(1):1-2. PubMed ID: 34608936
[No Abstract] [Full Text] [Related]
2. Treatment of children with COVID-19: update of the Italian Society of Pediatric Infectious Diseases position paper.
Venturini E; Montagnani C; Garazzino S; Donà D; Pierantoni L; Lo Vecchio A; Krzysztofiak A; Nicolini G; Bianchini S; Galli L; Villani A; Gattinara GC;
Ital J Pediatr; 2021 Oct; 47(1):199. PubMed ID: 34620212
[No Abstract] [Full Text] [Related]
3. Metagenomic Next-Generation Sequencing (mNGS): SARS-CoV-2 as an Example of the Technology's Potential Pediatric Infectious Disease Applications.
Handel AS; Muller WJ; Planet PJ
J Pediatric Infect Dis Soc; 2021 Dec; 10(Supplement_4):S69-S70. PubMed ID: 34951468
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Infectious Disease Specialists: An Answer to Social Media Misinformation on Coronavirus Disease 2019.
Scaggs Huang F; Spearman P; Baldwin N; Schaffzin JK
J Pediatric Infect Dis Soc; 2021 Aug; 10(6):703-705. PubMed ID: 33367773
[No Abstract] [Full Text] [Related]
5. Critically ill children in paediatric intensive care unit are no less susceptible to infectious diseases amid the COVID-19 pandemic.
Leung KKY; Hon KL; Ip P; Chan RWY
Hong Kong Med J; 2021 Dec; 27(6):461-463. PubMed ID: 34924364
[No Abstract] [Full Text] [Related]
6. Does SARS-CoV-2 truly cause infectious myopathy?
Finsterer J; Scorza FA
J Formos Med Assoc; 2021 Mar; 120(3):1032-1033. PubMed ID: 32917481
[No Abstract] [Full Text] [Related]
7. How easy will it really be to replicate the success of the covid-19 vaccine with neglected infectious diseases?
Sahota R
BMJ; 2021 Mar; 372():n678. PubMed ID: 33692023
[No Abstract] [Full Text] [Related]
8. Reduction in the incidence of infectious diseases during the COVID-19 pandemic: A hypothesis.
MohammadSadeghi A
Med Hypotheses; 2021 Jan; 146():110465. PubMed ID: 33360922
[No Abstract] [Full Text] [Related]
9. The COVID-19 epidemic and other notifiable infectious diseases in China.
Bai BK; Jiang QY; Hou J
Microbes Infect; 2022 Feb; 24(1):104881. PubMed ID: 34419605
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus: Pure Infectious Disease or Genetic Predisposition.
Darbeheshti F; Abolhassani H; Bashashati M; Ghavami S; Shahkarami S; Zoghi S; Gupta S; Orange JS; Ochs HD; Rezaei N
Adv Exp Med Biol; 2021; 1318():91-107. PubMed ID: 33973174
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan.
Rana MS; Usman M; Alam MM; Ikram A; Salman M; Zaidi SSZ; Umair M; Qadir M
J Infect; 2021 May; 82(5):e31-e32. PubMed ID: 33524424
[No Abstract] [Full Text] [Related]
12. Response to letter to the editor "Does SARS-CoV-2 truly cause infectious myopathy?".
Chang KC
J Formos Med Assoc; 2021 Mar; 120(3):1034-1035. PubMed ID: 32921536
[No Abstract] [Full Text] [Related]
13. Absence of long-range severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission from a highly infectious patient with undiagnosed coronavirus disease 2019 (COVID-19) in a positive-pressure room.
Rhee C; Baker MA; Tucker R; Klompas M
Infect Control Hosp Epidemiol; 2022 Jan; 43(1):108-109. PubMed ID: 34287114
[No Abstract] [Full Text] [Related]
14. Targeting Infectious Coronavirus Disease 2019 (COVID-19) with Artificial Intelligence (AI) Applications: Evidence Based Opinion.
Mali SN; Pratap AP
Infect Disord Drug Targets; 2021; 21(4):475-477. PubMed ID: 32568026
[No Abstract] [Full Text] [Related]
15. [Report of the Global Committee, a Survey of International Conferences Held Online due to the Effects of COVID-19 Infectious Diseases].
Takatsu Y; Tanaka R
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2021; 77(3):295-302. PubMed ID: 33746177
[No Abstract] [Full Text] [Related]
16. Impact of Coronavirus Disease 2019 (COVID-19) Pandemic on Pediatric Infectious Disease Research.
Bensoussan E; Ouldali N; Ashkenazi S; Angoulvant F; Cohen R; Levy C
J Pediatr; 2021 Mar; 230():279-281.e2. PubMed ID: 33271191
[No Abstract] [Full Text] [Related]
17. Infectious Disease Update: COVID-19 and Beyond.
Krilov LR
Pediatr Ann; 2022 May; 51(5):e178-e179. PubMed ID: 35575541
[No Abstract] [Full Text] [Related]
18. Surveillance in hospitalized children with infectious diseases in Japan: Pre- and post-coronavirus disease 2019.
Fukuda Y; Tsugawa T; Nagaoka Y; Ishii A; Nawa T; Togashi A; Kunizaki J; Hirakawa S; Iida J; Tanaka T; Kizawa T; Yamamoto D; Takeuchi R; Sakai Y; Kikuchi M; Nagai K; Asakura H; Tanaka R; Yoshida M; Hamada R; Kawasaki Y
J Infect Chemother; 2021 Nov; 27(11):1639-1647. PubMed ID: 34389224
[TBL] [Abstract][Full Text] [Related]
19. Use of personal protective equipment reduces the risk of contamination by highly infectious diseases such as COVID-19.
Dos Santos WM
Evid Based Nurs; 2021 Apr; 24(2):41. PubMed ID: 32788168
[No Abstract] [Full Text] [Related]
20. What happened to infectious diseases and anti-infective therapy in 2020 beyond COVID-19?
Mormeneo Bayo S; García-Lechuz Moya JM
Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):8-11. PubMed ID: 34598414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
